BlackRock Fund Advisors - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2016$28,758,000
+6.2%
1,025,225
+12.4%
0.01%
-16.7%
Q3 2016$27,080,000
+53.4%
911,788
+4.6%
0.01%
+50.0%
Q2 2016$17,654,000
+64.7%
871,793
+46.8%
0.00%
+100.0%
Q1 2016$10,722,000
-28.7%
594,012
+4.1%
0.00%
-33.3%
Q4 2015$15,031,000
+191.3%
570,657
+136.0%
0.00%
+200.0%
Q3 2015$5,160,000
-20.6%
241,810
-1.4%
0.00%
-50.0%
Q2 2015$6,497,000245,2550.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders